Metabolic Reprogramming and Renal Fibrosis

被引:24
|
作者
Zhu, Xiaoyu [1 ]
Jiang, Lili [2 ]
Long, Mengtuan [1 ]
Wei, Xuejiao [1 ]
Hou, Yue [1 ]
Du, Yujun [1 ]
机构
[1] First Hosp Jilin Univ, Dept Nephrol, Changchun, Peoples R China
[2] First Hosp Jilin Univ, Phys Examinat Ctr, Changchun, Peoples R China
关键词
renal fibrosis; chronic kidney disease; metabolic reprogramming; fatty acid; aerobic glycolysis; CHRONIC KIDNEY-DISEASE; PROLYL HYDROXYLASE INHIBITOR; TO-MESENCHYMAL TRANSITION; TUBULAR EPITHELIAL-CELLS; FATTY-ACID OXIDATION; AEROBIC GLYCOLYSIS; LIPID-METABOLISM; TGF-BETA; MYOFIBROBLAST DIFFERENTIATION; MITOCHONDRIAL-FUNCTION;
D O I
10.3389/fmed.2021.746920
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
There are several causes of chronic kidney disease, but all of these patients have renal fibrosis. Although many studies have examined the pathogenesis of renal fibrosis, there are still no effective treatments. A healthy and balanced metabolism is necessary for normal cell growth, proliferation, and function, but metabolic abnormalities can lead to pathological changes. Normal energy metabolism is particularly important for maintaining the structure and function of the kidneys because they consume large amounts of energy. We describe the metabolic reprogramming that occurs during renal fibrosis, which includes changes in fatty acid metabolism and glucose metabolism, and the relationship of these changes with renal fibrosis. We also describe the potential role of novel drugs that disrupt this metabolic reprogramming and the development of fibrosis, and current and future challenges in the treatment of fibrosis.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Metabolic reprogramming of pulmonary fibrosis
    Li, Jiaxin
    Zhai, Xiaoxuan
    Sun, Xiao
    Cao, Shengchuan
    Yuan, Qiuhuan
    Wang, Jiali
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [2] Metabolic Reprogramming of Liver Fibrosis
    Delgado, M. Eugenia
    Cardenas, Beatriz I.
    Farran, Nuria
    Fernandez, Mercedes
    [J]. CELLS, 2021, 10 (12)
  • [3] Metabolic reprogramming in liver fibrosis
    Horn, Paul
    Tacke, Frank
    [J]. CELL METABOLISM, 2024, 36 (07)
  • [4] Metabolic reprogramming in renal cancer: Events of a metabolic disease
    Chakraborty, Samik
    Balan, Murugabaskar
    Sabarwal, Akash
    Choueiri, Toni K.
    Pal, Soumitro
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2021, 1876 (01):
  • [5] Trim21 mediates metabolic reprogramming in renal tubular cells via PFKP ubiquitination to alleviate renal fibrosis
    Wen, Yang
    Tian, Maoqing
    Jiang, Xushun
    Gong, Ying
    Gan, Hua
    [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2024,
  • [6] Metabolic Reprogramming as a Driver of Fibroblast Activation in Pulmonary Fibrosis
    Para, Rachel
    Romero, Freddy
    George, Gautam
    Summer, Ross
    [J]. AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2019, 357 (05): : 394 - 398
  • [7] Molecular mechanisms underlying the role of hypoxia-inducible factor-1 α in metabolic reprogramming in renal fibrosis
    Wei, Xuejiao
    Hou, Yue
    Long, Mengtuan
    Jiang, Lili
    Du, Yujun
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [8] Mitochondria dysfunction and metabolic reprogramming as drivers of idiopathic pulmonary fibrosis
    Bueno, Marta
    Calyeca, Jazmin
    Rojas, Mauricio
    Mora, Ana L.
    [J]. REDOX BIOLOGY, 2020, 33
  • [9] METABOLIC CONDITIONING AND REPROGRAMMING ARE HALLMARKS OF NEUTROPHILIC INFLAMMATION IN CYSTIC FIBROSIS
    Tirouvanziam, R.
    Laval, J.
    Gudiputi, L.
    Touhami, J.
    Battini, J. -L.
    Conrad, C.
    Milla, C.
    Moss, R.
    Sitbon, M.
    Herzenberg, L.
    [J]. INFLAMMATION RESEARCH, 2011, 60 : 78 - 78
  • [10] Calponin 2 harnesses metabolic reprogramming to determine kidney fibrosis
    Gui, Yuan
    Wang, Yuanyuan
    Palanza, Zachary
    Wang, Jack L.
    Gupta, Priya
    Tao, Jianling
    Qiao, Yi
    Hargis, Geneva
    Kreutzer, Donald L.
    Bastacky, Sheldon I.
    Yu, Yanbao
    Wang, Yanlin
    Liu, Silvia
    Fu, Haiyan
    Zhou, Dong
    [J]. MOLECULAR METABOLISM, 2023, 71